Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hart

Showing results (881-890 of 909) with videos related to

Pageof 91
Sort By:
The Review of Scientific Instruments|September 1, 2022
The fluctuation-dissipation measurement instrument at the Linac Coherent Light SourceT A Assefa, M H Seaberg, A H Reid, et al.
BMC Health Services Research|November 4, 2025
The cost of drug repurposing: parallel economic evaluation of mirtazapine for severe breathlessness in the multinational BETTER-B trialPeter May, Charles Normand, Adejoke O Oluyase, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2026
Cognitive decline in Dutch-type hereditary and sporadic cerebral amyloid angiopathy: a 5-year follow-up studyRosemarie van Dort, Vera C J van Stek-Smits, Sanne E Schriemer, et al.
Nature|August 27, 2010
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALSAndrew C Elden, Hyung-Jun Kim, Michael P Hart, et al.
Haematologica|April 18, 2020
Identification of a homozygous recessive variant in <i>PTGS1</i> resulting in a congenital aspirin-like defect in platelet functionMelissa V Chan, Melissa A Hayman, Suthesh Sivapalaratnam, et al.
Blood|January 9, 2017
Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopeniaSuthesh Sivapalaratnam, Sarah K Westbury, Jonathan C Stephens, et al.
The Lancet. Respiratory Medicine|September 12, 2024
Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trialIrene J Higginson, Sarah T Brown, Adejoke O Oluyase, et al.
Elife|January 2, 2014
Multiple knockout mouse models reveal lincRNAs are required for life and brain developmentMartin Sauvageau, Loyal A Goff, Simona Lodato, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 6, 2021
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitorsMiguel Escobar, James Luck, Yevhenii Averianov, et al.
Nature Communications|April 5, 2020
Translational derepression of Elavl4 isoforms at their alternative 5' UTRs determines neuronal developmentTatiana Popovitchenko, Yongkyu Park, Nicholas F Page, et al.
Pageof 91

Showing results (881-890 of 909) with videos related to

Sort By:
Pageof 91
The Review of Scientific Instruments|September 1, 2022
The fluctuation-dissipation measurement instrument at the Linac Coherent Light SourceT A Assefa, M H Seaberg, A H Reid, et al.
BMC Health Services Research|November 4, 2025
The cost of drug repurposing: parallel economic evaluation of mirtazapine for severe breathlessness in the multinational BETTER-B trialPeter May, Charles Normand, Adejoke O Oluyase, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2026
Cognitive decline in Dutch-type hereditary and sporadic cerebral amyloid angiopathy: a 5-year follow-up studyRosemarie van Dort, Vera C J van Stek-Smits, Sanne E Schriemer, et al.
Nature|August 27, 2010
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALSAndrew C Elden, Hyung-Jun Kim, Michael P Hart, et al.
Haematologica|April 18, 2020
Identification of a homozygous recessive variant in <i>PTGS1</i> resulting in a congenital aspirin-like defect in platelet functionMelissa V Chan, Melissa A Hayman, Suthesh Sivapalaratnam, et al.
Blood|January 9, 2017
Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopeniaSuthesh Sivapalaratnam, Sarah K Westbury, Jonathan C Stephens, et al.
The Lancet. Respiratory Medicine|September 12, 2024
Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trialIrene J Higginson, Sarah T Brown, Adejoke O Oluyase, et al.
Elife|January 2, 2014
Multiple knockout mouse models reveal lincRNAs are required for life and brain developmentMartin Sauvageau, Loyal A Goff, Simona Lodato, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 6, 2021
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitorsMiguel Escobar, James Luck, Yevhenii Averianov, et al.
Nature Communications|April 5, 2020
Translational derepression of Elavl4 isoforms at their alternative 5' UTRs determines neuronal developmentTatiana Popovitchenko, Yongkyu Park, Nicholas F Page, et al.
Pageof 91